InvestorsHub Logo

XenaLives

12/08/17 3:19 PM

#133375 RE: Mprush #133373

Perhaps Denali at $18 a share preclinical would be a better bet ... no evidence of efficacy whatsoever in their Alzheimer's drug and possible toxicity.

ExtremelyBullishZig

12/08/17 9:46 PM

#133412 RE: Mprush #133373

Silence is platinum.